Metabolism pathways in chronic lymphocytic leukemia

References

• Hammoudi N, Ahmed KB, Garcia-Prieto C, et al. Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer 2011; 30: 508–525.
   PubMedGoogle Scholar
• Bentley DP, Pepper CJ. The apoptotic pathway: a target for therapy in chronic lymphocytic leukemia. Hematol Oncol 2000; 18: 87–98.
   PubMed Web of Science ®Google Scholar
• Dameshek W. Chronic lymphocytic leukemia – an accumulative disease of immunolgically incompetent lymphocytes. Blood 1967; 29: 566–584.
   PubMed Web of Science ®Google Scholar
• Kitada S, Pedersen IM, Schimmer AD, et al. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 2002; 21: 3459–3474.
   PubMed Web of Science ®Google Scholar
• Bueso-Ramos CE, Ferrajoli A, Medeiros LJ, et al. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells. Hematology 2004; 9: 279–286.
   PubMedGoogle Scholar
• Chiorazzi N. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells. Best Pract Res Clin Haematol 2007; 20: 399–413.
   PubMed Web of Science ®Google Scholar
• Bilban M, Heintel D, Scharl T, et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080–1088.
   PubMed Web of Science ®Google Scholar
• Neese RA, Misell LM, Turner S, et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci USA 2002; 99: 15345–15350.
   PubMed Web of Science ®Google Scholar
• Klement RJ, Kammerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) 2011; 8: 75.
   PubMed Web of Science ®Google Scholar
• A B. Wratschebnaje obosrnije 1921.
   Google Scholar
• Warburg O. Über den Stoffwechsel der Carzinomzelle. Klin Wochenschr 1925; 4: 534–536.
   Google Scholar
• Bhatt AP, Jacobs SR, Freemerman AJ, et al. Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci USA 2012; 109: 11818–11823.
   PubMed Web of Science ®Google Scholar
• Kim TM, Paeng JC, Chun IK, et al. Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma. Cancer 2013; 119: 1195–1202.
   PubMed Web of Science ®Google Scholar
• Lisker SA, Brody JI, Beizer LH. Abnormal carbohydrate metabolism in patients with malignant blood dyscrasias. Am J Med Sci 1966; 252: 282–288.
   PubMed Web of Science ®Google Scholar
• Brody JI, Oski FA, Singer DE. Impaired pentose phosphate shunt and decreased glycolytic activity in lymphocytes of chronic lymphocytic leukemia. Metabolic pathway. Blood 1969; 34: 421–429.
   PubMed Web of Science ®Google Scholar
• Brody JI, Merlie K. Metabolic and biosynthetic features of lymphocytes from patients with diabetes mellitus: similarities to lymphocytes in chronic lymphocytic leukaemia. Br J Haematol 1970; 19: 193–201.
   PubMed Web of Science ®Google Scholar
• Martinez Marignac VL, Smith S, Toban N, et al. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming. Oncotarget 2013; 4: 2550–2566.
   PubMed Web of Science ®Google Scholar
• Ryland LK, Doshi UA, Shanmugavelandy SS, et al. C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia. PLoS One 2013; 8: e84648.
   PubMed Web of Science ®Google Scholar
• Doughty CA, Bleiman BF, Wagner DJ, et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 2006; 107: 4458–4465.
   PubMed Web of Science ®Google Scholar
• Jerusalem G, Beguin Y, Najjar F, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 2001; 12: 825–830.
   PubMed Web of Science ®Google Scholar
• Karam M, Novak L, Cyriac J, et al. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107: 175–183.
   PubMed Web of Science ®Google Scholar
• Papajik T, Myslivecek M, Urbanova R, et al. 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. Leuk Lymphoma 2014; 55: 314–319.
   PubMed Web of Science ®Google Scholar
• Falchi L, Keating MJ, Marom EM, et al. Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood 2014; 123: 2783–2790.
   PubMed Web of Science ®Google Scholar
• Lipmann F. The ATP-phosphate cycle. Curr Top Cell Regul 1981; 18: 301–311.
   PubMedGoogle Scholar
• Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 1961; 191: 144–148.
   PubMed Web of Science ®Google Scholar
• Taanman JW. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1999; 1410: 103–123.
   PubMed Web of Science ®Google Scholar
• Clayton DA, Vinograd J. Circular dimer and catenate forms of mitochondrial DNA in human leukaemic leucocytes. Nature 1967; 216: 652–657.
   PubMed Web of Science ®Google Scholar
• Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482–1488.
   PubMed Web of Science ®Google Scholar
• Carew JS, Zhou Y, Albitar M, et al. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 2003; 17: 1437–1447.
   PubMed Web of Science ®Google Scholar
• Meierhofer D, Ebner S, Mayr JA, et al. Platelet transfusion can mimic somatic mtDNA mutations. Leukemia 2006; 20: 362–363.
   PubMed Web of Science ®Google Scholar
• Cerezo M, Bandelt HJ, Martin-Guerrero I, et al. High mitochondrial DNA stability in B-cell chronic lymphocytic leukemia. PLoS One 2009; 4: e7902.
   PubMed Web of Science ®Google Scholar
• Lan Q, Lim U, Liu CS, et al. A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma. Blood 2008; 112: 4247–4249.
   PubMed Web of Science ®Google Scholar
• Hosnijeh FS, Lan Q, Rothman N, et al. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort. Blood 2014; 124: 530–535.
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325–337.
   PubMed Web of Science ®Google Scholar
• Solaini G, Sgarbi G, Baracca A. Oxidative phosphorylation in cancer cells. Biochim Biophys Acta 2011; 1807: 534–542.
   PubMed Web of Science ®Google Scholar
• Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006; 5: 14.
   PubMedGoogle Scholar
• D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813–824.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579–591.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Hanson MG, Norell HR, et al. Preferential cell death of CD8 + effector memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative stress. J Immunol 2005; 174: 6080–6087.
   PubMed Web of Science ®Google Scholar
• Harlin H, Hanson M, Johansson CC, et al. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16 + CD56(dim) subset. J Immunol 2007; 179: 4513–4519.
   PubMed Web of Science ®Google Scholar
• Poschke I, Mougiakakos D, Kiessling R. Camouflage and sabotage: tumor escape from the immune system. Cancer Immunol Immunother 2011; 60: 1161–1171.
   PubMed Web of Science ®Google Scholar
• Aurelius J, Thoren FB, Akhiani AA, et al. Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis. Blood 2012; 119: 5832–5837.
   PubMed Web of Science ®Google Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 2013; 12: 931–947.
   PubMed Web of Science ®Google Scholar
• Jitschin R, Hofmann AD, Bruns H, et al. Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia. Blood 2014; 123: 2663–2672.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Hileman EO, Plunkett W, et al. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 2003; 101: 4098–4104.
   PubMed Web of Science ®Google Scholar
• Collado R, Oliver I, Tormos C, et al. Early ROS-mediated DNA damage and oxidative stress biomarkers in Monoclonal B Lymphocytosis. Cancer Lett 2012; 317: 144–149.
   PubMed Web of Science ®Google Scholar
• Adekola KU, Dalva Aydemir S, Ma S, et al. Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin. Leuk Lymphoma 2015; 56: 450–459.
   PubMed Web of Science ®Google Scholar
• Rozovski U, Wu JY, Harris DM, et al. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells. Blood 2014; 123: 3797–3802.
   PubMed Web of Science ®Google Scholar
• Wheeler ML, Defranco AL. Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation. J Immunol 2012; 189: 4405–4416.
   PubMed Web of Science ®Google Scholar
• Capasso M, Bhamrah MK, Henley T, et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol 2010; 11: 265–272.
   PubMed Web of Science ®Google Scholar
• Prinz C, Vasyutina E, Lohmann G, et al. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden. Mol Cancer 2015; 14: 114.
   PubMed Web of Science ®Google Scholar
• Zhang W, Trachootham D, Liu J, et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 2012; 14: 276–286.
   PubMed Web of Science ®Google Scholar
• Hildeman DA, Mitchell T, Kappler J, et al. T cell apoptosis and reactive oxygen species. J Clin Invest 2003; 111: 575–581.
   PubMed Web of Science ®Google Scholar
• Zivkovic M, Poljak-Blazi M, Zarkovic K, et al. Oxidative burst of neutrophils against melanoma B16-F10. Cancer Lett 2007; 246: 100–108.
   PubMed Web of Science ®Google Scholar
• Dallegri F, Ottonello L, Ballestrero A, et al. Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation 1991; 15: 15–30.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Lee YK, Bone ND, et al. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. Blood 2005; 105: 2099–2106.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
   PubMed Web of Science ®Google Scholar
• Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012; 21: 297–308.
   PubMed Web of Science ®Google Scholar
• Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) 2002; 80: 753–769.
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647.
   PubMed Web of Science ®Google Scholar
• Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625–1638.
   PubMed Web of Science ®Google Scholar
• Heintel D, Kienle D, Shehata M, et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216–1223.
   PubMed Web of Science ®Google Scholar
• Oppezzo P, Vasconcelos Y, Settegrana C, et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005; 106: 650–657.
   PubMed Web of Science ®Google Scholar
• Cahill N, Rosenquist R. Uncovering the DNA methylome in chronic lymphocytic leukemia. Epigenetics 2013; 8: 138–148.
   PubMed Web of Science ®Google Scholar
• Cahill N, Bergh AC, Kanduri M, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013; 27: 150–158.
   PubMed Web of Science ®Google Scholar
• A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011; 9: e1001046.
   PubMed Web of Science ®Google Scholar
• Messeguer X, Escudero R, Farre D, et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002; 18: 333–334.
   PubMed Web of Science ®Google Scholar
• Farre D, Roset R, Huerta M, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res 2003; 31: 3651–3653.
   PubMed Web of Science ®Google Scholar
• Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 2012; 30: 1005–1014.
   PubMed Web of Science ®Google Scholar
• Frank DA, Mahajan S, Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest 1997; 100: 3140–3148.
   PubMed Web of Science ®Google Scholar
• Hazan-Halevy I, Harris D, Liu Z, et al. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 2010; 115: 2852–2863.
   PubMed Web of Science ®Google Scholar
• Li P, Harris D, Liu Z, et al. STAT3-activated GM-CSFRalpha translocates to the nucleus and protects CLL cells from apoptosis. Mol Cancer Res 2014; 12: 1267–1282.
   PubMed Web of Science ®Google Scholar
• Li P, Harris D, Liu Z, et al. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One 2010; 5: e11859.
   PubMed Web of Science ®Google Scholar
• Bharti AC, Shishodia S, Reuben JM, et al. Nuclear factor-kappaB and STAT3 are constitutively active in CD138 + cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 2004; 103: 3175–3184.
   PubMed Web of Science ®Google Scholar
• Rozovski U, Grgurevic S, Bueso-Ramos C, et al. Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res 2015; 13: 944–953.
   PubMed Web of Science ®Google Scholar
• Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693–707.
   PubMed Web of Science ®Google Scholar
• Yavasoglu I PG, yilmaz F, Akgun G, et al. Cholesterol levels in patients with newly diagnosed chronic lymphocytic leukmia: a retrospective multicenter study. Am Soc Hematol 2013; 122.
   Google Scholar
• Till KJ, Pettitt AR, Slupsky JR. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase delta but not SYK or BTK in chronic lymphocytic leukemia cells. J Immunol 2015; 194: 2439–2446.
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille JJ, Luo Z, et al. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 2012; 120: 2631–2638.
   PubMed Web of Science ®Google Scholar
• Kersten S. Integrated physiology and systems biology of PPARalpha. Mol Metab 2014; 3: 354–371.
   PubMed Web of Science ®Google Scholar
• Ruby MA, Goldenson B, Orasanu G, et al. VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res 2010; 51: 2275–2281.
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz C, Morales A, Fernandez-Checa JC. Statins and protein prenylation in cancer cell biology and therapy. Anticancer Agents Med Chem 2012; 12: 303–315.
   PubMed Web of Science ®Google Scholar
• Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med 2012; 367: 1792–1802.
   PubMed Web of Science ®Google Scholar
• Hubal MJ, Reich KA, De Biase A, et al. Transcriptional deficits in oxidative phosphorylation with statin myopathy. Muscle Nerve 2011; 44: 393–401.
   PubMed Web of Science ®Google Scholar
• Yavasoglu I, Sargin G, Kadikoylu G, et al. The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro. Med Oncol 2013; 30: 603.
   PubMed Web of Science ®Google Scholar
• Chapman-Shimshoni D, Yuklea M, Radnay J, et al. Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Exp Hematol 2003; 31: 779–783.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Rabe KG, Kay NE, et al. Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia. Leuk Lymphoma 2010; 51: 1233–1240.
   PubMed Web of Science ®Google Scholar
• Chae YK, Trinh L, Jain P, et al. Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia. Blood 2014; 123: 1424–1426.
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Sanz Garcia N, et al. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012; 122: 253–270.
   PubMed Web of Science ®Google Scholar
• Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005; 330: 1304–1305.
   PubMed Web of Science ®Google Scholar
• Adekola KU, Dalva Aydemir S, Ma S, et al. Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin. Leuk Lymphoma 2015; 56: 450–459.
   PubMed Web of Science ®Google Scholar
• Spaner DE, Lee E, Shi Y, et al. PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia. Leukemia 2013; 27: 1090–1099.
   PubMed Web of Science ®Google Scholar
• Patel KP, Ravandi F, Ma D, et al. Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features. Am J Clin Pathol 2011; 135: 35–45.
   PubMed Web of Science ®Google Scholar
• Smith AE, Mohamedali AM, Kulasekararaj A, et al. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood 2010; 116: 3923–3932.
   PubMed Web of Science ®Google Scholar
• Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44: 47–52.
   PubMed Web of Science ®Google Scholar
• Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497–2506.
   PubMed Web of Science ®Google Scholar
• Harrison DA. The Jak/STAT pathway. Cold Spring Harb Perspect Biol 2012; 4: a011205.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 2012; 148: 1132–1144.
   PubMed Web of Science ®Google Scholar